Abiopharma

Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock

AbbVie Reports Third-Quarter 2025 Financial Results

Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy

Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025

Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference

Fortive to Present at Baird’s 2025 Global Industrial Conference

Zai Lab Announces Participation in Investor Conferences in November and December 2025

TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update

Stevanato Group to Participate in Upcoming Investor Conferences

Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025